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A 260 kDa cytosolic complex @P-l) was purified from guinea pig neutrophils. SP-1 was composed of 63 kDa, 47 kDa and 39 kDa proteins. The 
63 kDa and 47 kDa proteins proved to correspond to human ~67~~“” and p47rhox by Western blot analysis, whereas Western blot and amino acid 
sequence analyses revealed that the 39 kDa protein was a novel protein. The 47 kDa protein was separated from the 63 kDa and 39 kDa proteins 
by dithiothreitol (DTT)-treatment. On the other hand, the 63 kDa and 39 kDa proteins were not separated with DTT, detergent and ethanol 
treatment. These results suggest hat the 39 kDa protein tightly associates with the 63 kDa protein and may regulate the function of the 63 kDa 
protein. 
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1. INTRODUCTION attempted to purify SP-1, to elucidate its activation 
mechanisms of NADPH oxidase. 
The production of superoxide (O;), which is catalyzed 
by NADPH oxidase, is essential for microbicidal and 
cytotoxic activities of neutrophils and other profes- 
sional phagocytic cells [l]. NADPH oxidase is a multi- 
component enzyme consisting of a plasma membrane- 
bound cytochrome b,,, [2-61 and cytosolic proteins, 
such as p47*” and ~67~“” [7-121. ~47~~“” and ~67~~“” 
are translocated to the membrane when the oxidase is 
activated [13,141. Recently, small GTP-binding proteins 
(racl, rac2 and Krevl) have been reported to be the 
cytosolic components which participate in the oxidase 
activation [15-l 73. 
2. MATERIALS AND METHODS 
2.1. Preparation of neutrophils 
Guinea pig neutrophils were isolated from the peritoneal cavity 
13-l 5 h after an intraperitoneal injection of 0.17% glycogen as previ- 
ously described [22]. 
2.2. Preparation of the cytosol and membrane fractions 
Large molecular cytosolic complexes (> 100 kDa) 
which are involved in superoxide production have been 
obtained from cytosol by gel filtration chromatography 
[ 18,191 or ammonium sulfate precipitation [20]. Re- 
cently, a 250 kDa cytosolic complex has been isolated 
from human neutrophils and proved to contain both 
p47Ph”” and p67*“” [14], suggesting that these proteins 
may exist as a complex in neutrophils. We have sepa- 
rated three cytosolic factors @P-l, QA-1 and QA-2) 
from guinea pig neutrophils using ion-exchange col- 
umns, and have showed that SP-1 but not QA-1 and 
QA-2 activates NADPH oxidase by itself. SP-1 was a 
260 kDa complex with a few components, including a 
47 kDa protein [21]. Therefore, in the present study, we 
Neutrophils (2 x 10’ cells/ml) were pretreated with 5 mM diisopro- 
pyl fluorophosphate in phosphate-buffered saline (PBS: 137 mM 
NaCl, 2.7 mM KCl, 8.1 mM Na,HPO,, 1.5 mM KH2P04, pH 7.4), for 
30 min at 4°C. After washing with PBS, neutrophils were resuspended 
in ice-cold 0.34 M sucrose buffer (131 mM NaCl, 8 mM KH,PO,, 0.34 
M sucrose containing 1 mM EGTA, 0.8 mM PMSF, 10 &ml pep- 
statin, and 50 &ml leupeptin, pH 7.0) at 2 x lo* cells/ml, and dis- 
rupted by sonication on ice using a sonicator. The sonicate was centri- 
fuged at 8,500 x g for 15 min at 4”C, and the resulting supematant 
was further centrifuged at 260,000 x g for 1 h at 4’C. The obtained 
supematant, i.e. the cytosol fraction, was used as starting material 
for the purification of cytosolic factors. The pellet was resus- 
pended in 0.34 M sucrose buffer and used as the membrane fraction 
[21]. The cytosol and the membrane fractions were stored at -80°C 
until use. 
2.3. Purifcation of the SP-I cytosolic omplex 
*Corresponding author. Fax: (81) (3) 3814 9300. 
Abbreviations: p4?“““, 47 kDa cytosolic phagocyte oxidase compo- 
nent; p67phox, 67 kDa cytosolic phagocyte oxidase component; PMSF, 
phenylmethanesulfony1 fluoride. 
To change the buffer, the cytosol fraction (70 ml, containing 500 mg 
protein) was filtered through a Sephadex G-25 column (2.6 x 100 cm, 
Pharmacia LKB Biotechnology, Sweden) equilibrated with 20 mM 
sodium phosphate buffer, pH 7.0, containing 0.5 mM EGTA and 0.5 
mM PMSF (Buffer A). Almost all activity was recovered in a void 
fraction. The void fraction was applied to a S-Sepharose Fast-Flow 
column (26 x 40 mm, Pharmacia LKB Biotechnology) equilibrated 
with Buffer A, and the column was eluted with a linear O-300 mM 
NaCl gradient at a flow rate of 3.0 ml/min. The active fraction, SP-1, 
(total volume of 78 ml) obtained from the S-Sepharose Fast-Flow 
chromatography was dialyzed against a 10 mM sodium phosphate 
buffer (pH 7.0), and concentrated using PM10 diafro ultrafilters with 
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a molecular mass cut-off of 10 kDa (Amicon Co., Ireland). Concen- 
trated SP-1 (about 50 ml) was applied to a Biofine HAC-5CP hydrox- 
yapatite column (7.5 x 75 mm, JASCO-JAPAN Spectroscopic Co., 
Japan) equilibrated with a 10 mM sodium phosphate buffer, pH 7.0, 
containing 0.17 M sucrose. After washing with equilibration buffer, 
the column was eluted with a linear gradient of 10-300 mM sodium 
phosphate at a flow rate of 1.0 ml/min. The active fraction (about 7 
ml) was mixed with 5 volumes of Buffer A to decrease the salt concen- 
tration, and was applied to a Cosmogel CM column (8 x 75 mm, 
Nacalai tesque Inc., Japan) equilibrated with Buffer A. The column 
was eluted with a linear gradient of &500 mM NaCl at a flow rate of 
1 .O ml/min. The active fraction (about 5 ml) was concentrated using 
PM10 diafro ultrafilters to a volume of 2 ml, and 400 ~1 was injected 
to a Superose 12HR gel filtration column (10 x 300 mm, Pharmacia 
LKB Biotechnology) equilibrated with a 20 mM sodium phosphate 
buffer, pH 7.0, containing 0.13 M NaCl, 0.5 mM PMSF, and 1 mM 
EGTA. The flow rate was 0.5 ml/min. 
2.4. Assay of NADPH oxidase activity in a cell-free system 
Assay of NADPH oxidase was performed in a cell-free system as 
described previously [21]. 
The assay mixture (0.5 ml) consisted of 80 PM cytochrome c, 5 mM 
MgCl,, 10 PM FAD, 20 PM arachidonic acid, 15 pg membrane frac- 
tion and each fraction from HPLC in 65 mM sodium phosphate 
buffer, pH 7.0, containing 0.17 M sucrose. After a 40 s incubation at 
37°C. the reaction was started by the addition of 200 PM NADPH. 
The reduction of cytochrome cwas measured at 550-540 nm continu- 
ously. 
2.5. Hydrophobic chromatography of purified SP-I 
Purified SP-1 was mixed with three volumes of 100 mM sodium 
phosphate buffer, pH 7.0, containing 2.5 mM dithiothreitol (DTT) 
and 5 mM EGTA. After stirring for 30 min at 4°C. 5 M ammonium 
sulfate solution (adjusted to pH 7.0 with ammonium hydroxide) was 
added to the mixture to reach a final concentration of approximately 
1.0 M. The mixture was stirred for 2 h at 4°C. and was centrifuged 
at 48,000 x g for 20 min at 4°C. The obtained supernatant was applied 
to a Phenyl-TOYOPEARL 650 column (4 x 50 mm, TOSOH Corp., 
Japan) equilibrated with 20 mM sodium phosphate buffer, pH 7.0, 
containing 1.0 M ammonium sulfate, 500,~M DTT and 1 mM EGTA. 
The column was eluted with a 1.0-O M ammonium sulfate gradient 
at a flow rate of 0.7 ml/min. 
2.6. Polyacrylamide gel electrophoresis 
SDS-PAGE was carried out with a 5-138 linear gradient gel in 
0.1% SDS by the method of Laemmli and Favere [23]. Samples were 
treated with 5% 2-mercaptoethanol at100°C for 3 min under standard 
conditions. The gel was silver-stained using a commercially available 
reagent kit (Daiichi Pure Chemicals Co., Japan). 
2.7. Immunoblot analysis 
The purified SP-1 was subjected to SDS-PAGE and was electroblot- 
ted onto a nitrocellulose membrane according to the method of Tow- 
bin et al. [24]. The membrane was incubated with a Block Ace (Dainip- 
pon Pharmaceutical Co. Ltd., Japan), and then reacted with a 1 : 2000 
dilution of anti-human p47phox or anti-human ~67~~“” monoclonal 
antibody. The proteins were finally detected with a 1 : 1000 dilution 
of horseradish peroxidase-conjugated goat anti-mouse IgG followed 
by development with diformazan using the POD Immunostain Set 
(Wako Pure Chemical Industries Ltd., Japan). 
2.8. Analysis of amino acid sequence 
The purified SP-1 (about 100 pmol) was subjected to SDS-PAGE 
and was electroblotted onto a polyvinylidine fluoride (PVDF) mem- 
brane (Millipore Co., Bedford) as described previously [25]. The 
PVDF membrane was stained with Ponceau S, and then the band (39 
kDa) was excised and used for the analysis. After the treatment of 
reduction and S-carboxymethylation ofPVDF-blotted protein, in situ 
digestion of the S-carboxymethylated 39 kDa protein was performed 
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Fig. 1. Chromatographic purification of SP-1. (A) S-Sepharose Fast- 
Flow chromatography. The desalted cytosol fraction was applied to 
a S-Sepharose Fast-Flow column, and eluted with a O-300 mM NaCl 
gradient with a fraction size of 6 ml. Aliquots (40~1) were assayed for 
the NADPH oxidase activity. (B) HAC-5CP chromatography. The 
fractions indicated by the bar in the S-Sepharose Fast-Flow chroma- 
tography were applied to a HAC-5CP column, and eluted with a 
l&300 mM sodium phosphate gradient with a fraction size of 1 ml. 
Aliquots (10 ~1) were assayed for NADPH oxidase activity. (C) Cos- 
mogel CM chromatography. The fractions indicated by the bar in the 
HAC-5CP chromatography were applied to a Cosmogel CM column, 
and eluted with a O-500 mM NaCl gradient with a fraction size of 1 
ml. Aliquots (10~1) were assayed for the NADPH oxidase activity. (D) 
Superose 12HR chromatography. SP-1 fraction obtained from the 
Cosmogel CM chromatography indicated by the bar was applied to 
a Superose 12HR column. Fractions of 0.5 ml were corrected, and 30 
~1 aliquots were assayed for the NADPH oxidase activity. Allows 
show eluting position of molecular weight standards: 1, ferritin (440 
kDa); 2, catalase (232 kDa); 3, bovine serum albumin (67 kDa). 
by the method of Iwamatsu [26]. The membrane was treated with 0.5% 
polyvinylpyrrolidone (PVP-40) at 37°C for 30 min and cut into small 
pieces, and then the protein on the membrane was digested with lysyl 
endopeptidase (Wako Pure Chemical Industries Ltd., Japan) at 35°C 
for 16 h in 50 mM Tris-HCl, pH 9.0, containing 9% acetonitrile at an 
enzyme-to-substrate ration of 1 : 100 (mollmol). Two major peaks 
were separated by HPLC using a p-Bondasphere 5 ,&8-300A 
(2.1 x 150 mm, Millipore Co.) with a gradient of 2270% acetonitrile 
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Fig. 2. SDS-PAGE and immunoblot analyses of purified SP-1. Lane 
1, silver staining pattern; lane 2, immunoblot analysis with anti-human 
p67@“” antibody; lane 3, immunoblot analysis with anti-human p47phox 
antibody. Molecular weight standards are indicated on the right. 
in 0.05% trifluoroacetic acid. Amino acid sequences of the two peaks 
were analyzed on an automated Applied Biosystems gas-phase se- 
quencer (447A) equipped with an on-line PTH-amino acid analyzer 
(Model 120A). 
3. RESULTS AND DISCUSSION 
As reported previously, we separated SP-1 using a 
cation-exchange column [21]. Fig. 1A shows an elution 
profile of cytosol fraction on a S-Sepharose Fast-Flow 
cation-exchange chromatography. A single peak of ac- 
tivity (SP-1) was eluted at about 0.18 M NaCl, and was 
further purified using a HAC-5CP hydroxyapatite col- 
umn (Fig. 1B) followed by a Cosmogel CM cation- 
exchange column (Fig. IC). SP-1 was eluted from those 
columns at 250 mM sodium phosphate and 380 mM 
NaCl, respectively. 
SP-1 eluted from the Cosmogel CM HPLC was ap- 
plied to a Superose 12HR column, and purified as a 
single protein peak with a molecular weight of 260 kDa 
(Fig. 1D). From 500 mg of cytosol protein, 0.12 mg of 
SP-1 was recovered. The yield was 17%, and the in- 
crease in the activity was 25.6-fold. 
When purified SP-1 was analyzed on SDS-PAGE, 63 
kDa, 47 kDa and 39 kDa protein bands were observed 
(Fig. 2, lane 1). Under reducing and non-reducing con- 
ditions, the same SDS-PAGE pattern was observed 
(data not shown), suggesting that these three proteins 
were not joined by disulfide bonds. The 63 kDa and 47 
kDa proteins proved to correspond to human ~67~~‘” 
and p47phox, respectively, from the results of Western 
blot analysis using anti-human ~67~~“” and anti-human 
p47Ph”” antibodies (Fig. 2, lanes 2 and 3). On the other 
hand, the 39 kDa protein band did not react with either 
antibody. Furthermore, the amino acid sequences of the 
two peptides obtained from the lysyl endopeptidase- 
digested 39 kDa protein (peptide 1, LHITQQDNYS- 
VYNTTPSATQ; peptide 2, DIAVEEDLSSTPPF) did 
not exhibit homology to the amino acid sequences of 
p67pho”, ~47~~“” and small GTP-binding proteins re- 
ported so far. These results indicate that the 39 kDa 
protein is a novel protein different from the 63 kDa, 47 
kDa and small GTP-binding proteins. 
Fig. 3 illustrates a typical profile of hydrophobic in- 
teraction chromatography of SP-1. After treatment with 
500 PM DTT, SP-1 was applied to a Phenyl-TOYO- 
PEARL 650 column equilibrated with a DTT-contain- 
ing buffer. Of the three proteins of SP-1, the 47 kDa 
protein was eluted at about 0.45 M ammonium sulfate, 
but the 63 kDa and 39 kDa proteins were eluted as a 
complex at about 0.05 M ammonium sulfate. Next, 
after pretreatment with DTT, detergents (3-[(3-chol- 
amidpropyl)dimethylammonio]-1-propanesulfonate 
(CHAPS), n-octyl+o-glucoside or nonidet P-40) and 
ethanol, SP-1 was applied to a DEAE anion-exchange 
column equilibrated with 20 mM HEPES, pH 7.5, con- 
taining these reagents. The 47 kDa protein was not 
adsorbed on the DEAE column, whereas the 63 kDa 
and 39 kDa proteins were adsorbed on the column and 
eluted as a complex at 0.25 M NaCl (data not shown). 
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Fig. 3. Hydrophobic chromatography of purified SP-1. After pretreatment with DTT as described in section 2, SP-1 was applied to a Phenyl- 
TOYOPEARL 650 column, and eluted with a 1.04) M ammonium sulfate gradient. Fractions of 0.7 ml were collected. Insert: SDS-PAGE analysis 
of fractions 28 and 41 obtained from the chromatography. A front peak (fractions l-9) did not contain protein. 
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Therefore, the 63 kDa and 39 kDa proteins seem to 
associate tightly with each other. 
At this stage, a role of the 39 kDa protein in superox- 
ide production is not clear. However, as the 39 kDa 
protein tightly associates with the 63 kDa protein, the 
39 kDa protein seems to regulate the function of the 63 
kDa protein, for example, its interaction with the 47 
kDa protein. 
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